Provided by Tiger Trade Technology Pte. Ltd.

BEONE MEDICINES

206.200
-0.800-0.39%
Volume:5.42M
Turnover:1.11B
Market Cap:317.96B
PE:138.33
High:206.200
Open:203.600
Low:201.600
Close:207.000
52wk High:235.600
52wk Low:153.000
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:1.51
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.491
ROE:14.66%
ROA:7.46%
PB:7.83
PE(LYR):138.33
PS:6.61

Loading ...

Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates

Deep News
·
Aug 18

HK Movers | Pharma Stocks Rally With Genscript Biotech up 6%, WuXi Biologics up 5%

Tiger Newspress
·
Aug 18

Movement Alert|BEONE MEDICINES Intraday Rise 3.08%, JPMorgan Increases Stake to 9.05% Boosting Market Confidence

Market Focus
·
Aug 18

JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each

Stock News
·
Aug 14

BeOne Medicines Schedules 26 Aug 2026 Audit Committee Meeting to Approve 1H26 Results Aligned with Earlier U.S. Filing

Bulletin Express
·
Aug 14

BEONE MEDICINES: JPMorgan Chase & Co. Acquires Shares, Long Position Rises to 9.05%

HK Disclosure
·
Aug 14

Movement Alert|BEONE MEDICINES Declines 3.01% in Regular Trading, CEO Sells Shares Worth Nearly $20 Million

Market Focus
·
Aug 14

BEONE MEDICINES: John Victor Oyler Disposes of US ADR Shares

HK Disclosure
·
Aug 13

BeOne Medicines Ltd.: John Victor Oyler Disposes of US ADR Shares

HK Disclosure
·
Aug 13

Beone Medicines Awards Over 40,000 Restricted Stock Units to Employees

Stock News
·
Aug 13

Pharmaceutical Rally Continues: Gan&Lee Pharmaceuticals Hits Limit-Up, Beone Medicines Logs 6-Day Winning Streak; Huabao Funds' HK Medical and Innovation Drug ETFs Rise for Third Consecutive Session

Deep News
·
Aug 11

HK Movers | Hong Kong Biotech Stocks Rally; Genscript Bio Jumps Over 7%, Zai Lab Gains Over 6%

Tiger Newspress
·
Aug 11

CICC Retains Outperform Rating on BeiGene (06160) with HKD 266 Price Target

Stock News
·
Aug 11

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

Stock News
·
Aug 11

Movement Alert|BEONE MEDICINES Intraday Rise 3.94% in Regular Trading, Clinical Collaboration with Revolution Medicines on RAS Combination Therapies

Market Focus
·
Aug 11

BOCOM International Lifts BEONE MEDICINES Price Target to HKD 276, Maintains Buy Rating

Stock News
·
Aug 10

Movement Alert|BEONE MEDICINES Rises 3.05% in Regular Trading, Q2 Earnings Massively Beat Expectations as Multiple Banks Raise Target Prices

Market Focus
·
Aug 10

Goldman Sachs Competitor Adjusts BeOne Medicines Target Upward, Bullish Ratings Maintained

Deep News
·
Aug 09

BEONE MEDICINES Confirms External CMO Supply for Baiyueda, All Processes On Schedule

Deep News
·
Aug 07

BEONE MEDICINES: Approximately 95% of Pancreatic Cancer Cases Show KRAS Mutation, Around 20% Exhibit MTAP Deletion, Enabling Easy Identification of Overlapping Patient Groups

Deep News
·
Aug 07